Business
Integrated DNA Technologies Launches New Enhancer Protein to Accelerate CRISPR-Based Therapies from Translational Research to Clinical Breakthrough
CORALVILLE, Iowa, September 25, 2025--New enhancer protein expands IDT's market-leading portfolio of HDR reagents, empowering cell and gene therapy developers to accelerate discoveries
About this update from Danaher Corporation
[{"type":"image","alt":"Global genomics leader Integrated DNA Technologies is driving innovation and leadership in CRISPR with the launch of Alt-R™ HDR Enhancer Protein, a newly developed solution designed to facilitate an up to two-fold increase in HDR efficiency in challenging cells.","displaySize":"","headline":null,"caption":"Global genomics leader Integrated DNA Technologies is driving innovation and leadership in CRISPR with the launch of Alt-R™ HDR Enhancer Protein, a newly developed solution designed to facilitate an up to two-fold increase in HDR efficiency in challenging cells.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":270,"url":"https://media.zenfs.com/en/business-wire.com/f0c3b70725af5dccbfa14793f418d1b6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/7fjmNuCZDu51T75dD.26xA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/f0c3b70725af5dccbfa14793f418d1b6","width":480,"height":270},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/rlQT6npYDx_LA8EoC.q55A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTM2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/f0c3b70725af5dccbfa14793f418d1b6","width":480,"height":270}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4000,"height":1130,"url":"https://media.zenfs.com/en/business-wire.com/5a17b88df91c9c4a2cd0e319ed898f54"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XlNEK0H7OFXcOgCgCqWtXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI3MTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5a17b88df91c9c4a2cd0e319ed898f54","width":960,"height":271},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/gqMkR..geZTsrVWweI2R_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE4MTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5a17b88df91c9c4a2cd0e319ed898f54","width":640,"height":181},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/7tUmtbDRsrw8bY24rB_afQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02Nzg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/5a17b88df91c9c4a2cd0e319ed898f54","width":1200,"height":339}}},{"type":"text","content":"Research grade recombinant protein expands toolkit of available CRISPR nucleases and increases efficiency of homology-directed repair...